Getinge (OTCMKTS:GNGBY – Get Free Report) crossed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $20.41 and traded as high as $20.83. Getinge shares last traded at $20.80, with a volume of 1,128 shares changing hands.
Analysts Set New Price Targets
Separately, Zacks Research upgraded Getinge to a “hold” rating in a research report on Thursday, April 23rd. One equities research analyst has rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy”.
Read Our Latest Report on GNGBY
Getinge Price Performance
Getinge Company Profile
Getinge AB is a global medical technology company that develops, manufactures and markets products and systems for hospitals and life sciences institutions. The company’s offerings focus on critical care, surgical workflows and infection control, aiming to improve clinical outcomes and operational efficiency. Getinge’s solutions support a range of applications from intensive care and cardiovascular treatments to sterile reprocessing of surgical instruments.
The company’s product portfolio includes sterilization and disinfection equipment, surgical tables and lights, ventilation systems, heart-lung machines and extracorporeal membrane oxygenation (ECMO) devices.
Featured Articles
- Five stocks we like better than Getinge
- AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
- Why Kroger’s Giant Eagle Deal Could Change Everything
Receive News & Ratings for Getinge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Getinge and related companies with MarketBeat.com's FREE daily email newsletter.
